-DOCSTART- -X- O
Suppresors -X- _ O
of -X- _ O
cytokine -X- _ O
signaling -X- _ O
( -X- _ O
SOCS -X- _ O
) -X- _ O
proteins -X- _ O
regulate -X- _ O
cytokine -X- _ O
responses -X- _ O
and -X- _ O
control -X- _ O
immune -X- _ O
balance. -X- _ O
Several -X- _ O
studies -X- _ O
have -X- _ O
confirmed -X- _ O
that -X- _ O
SOCS3 -X- _ O
is -X- _ O
increased -X- _ O
in -X- _ O
asthmatic -X- _ O
patients -X- _ O
, -X- _ O
and -X- _ O
SOCS3 -X- _ O
expression -X- _ O
is -X- _ O
correlated -X- _ O
with -X- _ O
disease -X- _ O
severity. -X- _ O
The -X- _ O
objective -X- _ O
of -X- _ O
this -X- _ O
study -X- _ O
was -X- _ O
to -X- _ O
evaluate -X- _ O
if -X- _ O
delivering -X- _ B-Intervention
of -X- _ I-Intervention
SOCS3 -X- _ I-Intervention
short -X- _ I-Intervention
interfering -X- _ I-Intervention
RNA -X- _ I-Intervention
( -X- _ I-Intervention
siRNA -X- _ I-Intervention
) -X- _ I-Intervention
intranasally -X- _ I-Intervention
in -X- _ O
lungs -X- _ O
could -X- _ O
be -X- _ O
a -X- _ O
good -X- _ O
therapeutic -X- _ O
approach -X- _ O
in -X- _ O
an -X- _ O
asthma -X- _ B-Patient
chronic -X- _ I-Patient
mouse -X- _ I-Patient
model. -X- _ I-Patient
Our -X- _ O
results -X- _ O
showed -X- _ O
that -X- _ O
intranasal -X- _ B-Outcome
treatment -X- _ I-Outcome
with -X- _ I-Outcome
SOCS3-siRNA -X- _ I-Outcome
led -X- _ I-Outcome
to -X- _ I-Outcome
an -X- _ I-Outcome
improvement -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
eosinophil -X- _ I-Outcome
count -X- _ I-Outcome
and -X- _ I-Outcome
the -X- _ I-Outcome
normalization -X- _ I-Outcome
of -X- _ I-Outcome
hyperresponsiveness -X- _ I-Outcome
to -X- _ I-Outcome
methacholine. -X- _ I-Outcome
Concomitantly -X- _ O
, -X- _ O
this -X- _ O
treatment -X- _ O
resulted -X- _ O
in -X- _ O
an -X- _ O
improvement -X- _ B-Outcome
in -X- _ I-Outcome
mucus -X- _ I-Outcome
secretion -X- _ I-Outcome
, -X- _ I-Outcome
a -X- _ I-Outcome
reduction -X- _ I-Outcome
in -X- _ I-Outcome
lung -X- _ I-Outcome
collagen -X- _ I-Outcome
, -X- _ O
which -X- _ O
are -X- _ O
prominent -X- _ O
features -X- _ O
of -X- _ O
airway -X- _ O
remodeling. -X- _ O
The -X- _ O
mechanism -X- _ O
implies -X- _ O
JAK -X- _ O
/ -X- _ O
STAT -X- _ O
and -X- _ O
RhoA -X- _ O
/ -X- _ O
Rho-kinase -X- _ O
signaling -X- _ O
pathway -X- _ O
, -X- _ O
because -X- _ O
we -X- _ O
found -X- _ O
a -X- _ O
decreasing -X- _ O
in -X- _ O
STAT3 -X- _ O
phosphorylation -X- _ O
status -X- _ O
and -X- _ O
down -X- _ O
regulation -X- _ O
of -X- _ O
RhoA -X- _ O
/ -X- _ O
Rho-kinase -X- _ O
protein -X- _ O
expression. -X- _ O
These -X- _ O
results -X- _ O
might -X- _ O
lead -X- _ O
to -X- _ O
a -X- _ O
new -X- _ O
therapy -X- _ O
for -X- _ O
the -X- _ O
treatment -X- _ O
of -X- _ O
chronic -X- _ O
asthma -X- _ O
. -X- _ O

